Implant
Landmark Study Reveals New Technology from DeBogy Molecular Significantly Reduces the Bacteria and Deadly Infection that Can Occur Following a Surgical Implant
FARMINGTON, Conn.–(BUSINESS WIRE)–DeBogy Molecular, Inc, a biotech startup that specializes in antimicrobial surface modification, today announced the findings of a landmark in vivo research study that affirms the effectiveness and safety of their new technology to kill the dangerous bacteria that proliferates on the surface of a medical implant following surgery. Infection resulting from bacterial …
FDA clears Biorez BioBrace implant technology
Biorez announced that it received FDA 510(k) clearance for two sizes of its BioBrace implant for tendon and ligament procedures. New Haven, Conn.-based Biorez designed its biocomposite soft tissue scaffold for use in a range of surgical procedures to reinforce soft tissue where weakness exists, according to a news release. The implant can be used …
DEXA Technology™ —The World’s First Patient-Matched Interbody Implant Technology to Enable Improved Spine Surgery TSX Venture Exchange:ASG
CARLSBAD, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) today announced it has received “Notice of Allowance” for its patent from the United States Patent and Trademark Office (USPTO) for Patient-Matched Interbody Implant Technology. This patent will be utilized to create spinal implants that match the …
New technology to improve dental implant bridges receives US patent
New technology to improve dental implant bridges invented by Dr. Avinash Bidra, associate professor at the UConn School of Dental Medicine, recently received a patent from the United States Patent and Trademark Office. This is Bidra’s first patent, and the 22nd patent for the School of Dental Medicine As a prosthodontist, this is an …
An Arm Implant to Block HIV: Brainstorm Health
We write about all kinds of cool (and, more importantly, useful) science here at Brainstorm Health Daily. Perhaps none are quite as cool as technologies that can prevent horrible diseases while maximizing user convenience. And that’s exactly what Merck, the U.S.-based pharma giant, is setting out to do with its experimental HIV treatment combination that …
